Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study

References

• Bui HDT, Jing X, Lu R, et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study. Ann Transl Med. 2019;7(14).
   PubMedGoogle Scholar
• Aldemir O, Turgut F, Gokce C. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease. Ren Fail. 2017;39(1):597–601. doi:10.1080/0886022X.2017.1358180
   PubMed Web of Science ®Google Scholar
• Dal Canto E, Ceriello A, Ryden L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2_SUPPL):25–32. doi:10.1177/2047487319878371
   PubMed Web of Science ®Google Scholar
• Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9(9):523–528. doi:10.1038/nrneph.2013.146
   PubMed Web of Science ®Google Scholar
• Kute VB, Godara SM, Shah PR, et al. Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country. Int Urol Nephrol. 2012;44(1):269–274.
   PubMedGoogle Scholar
• Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl Supplement 1):s84–s87. doi:10.2337/diacare.27.2007.S84
   PubMedGoogle Scholar
• Kainz A, Hronsky M, Stel VS, et al. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant. 2015;30(suppl_4):iv113–iv118.
   PubMedGoogle Scholar
• Mellati AA, Tabaei BS, Alavi M, et al. Association of serum zinc and vitamin a levels with severity of retinopathy in type 2 diabetic patients: a cross-sectional study. Biol Trace Elem Res. 2019;192(2):123–128.
   PubMedGoogle Scholar
• Zhang J, Wang Y, Li L, et al. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy. Ren Fail. 2018;40(1):243–251.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Elwali ES, Awadalla H, et al. The relationship between diabetic retinopathy and nephropathy in Sudanese adult with diabetes: population based study. Diabetes Metab Syndr. 2017;11:S333–S336.
   PubMedGoogle Scholar
• Das D, Gupta S. Diabetic retinopathy in patients of type2 diabetes mellitus with diabetic nephropathy. Int J Scie Res. 2020;9(1).
   Google Scholar
• He F, Xia X, Wu X, et al. Diabetic Retinopathy in Predicting Diabetic Nephropathy in Patients with Type 2 Diabetes and Renal Disease: A Meta-Analysis. Springer; 2013.
   Google Scholar
• Prakash J, Lodha M, Singh S, et al. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients. J Assoc Physicians India. 2007;55:412–416.
   PubMedGoogle Scholar
• Cao X, Gong X, Ma X, et al. Diabetic nephropathy versus diabetic retinopathy in a Chinese population: a retrospective study. Med Sci Monit. 2019;25:6446. doi:10.12659/MSM.915917
   PubMedGoogle Scholar
• Niu W, Qi Y. An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy. Diabetes Res Clin Pract. 2012;95(1):110–118. doi:10.1016/j.diabres.2011.10.009
   PubMed Web of Science ®Google Scholar
• Klein R, Zinman B, Gardiner R, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin system study. Diabetes. 2005;54(2):527–533.
   PubMedGoogle Scholar
• Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, et al. Incidence of retinopathy in type I [insulin-dependent] diabetes: association with clinical nephropathy. J Diabetes Complications. 1987;1(3):96–99.
   Google Scholar
• Yang J-K, Wang -Y-Y, Liu C, et al. Urine proteome specific for eye damage can predict kidney damage in patients with type 2 diabetes: a case-control and a 5.3-year prospective cohort study. Diabetes care. 2017;40(2):253–260.
   PubMedGoogle Scholar
• Yan ZP, Ma JX. Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(8):1194.
   PubMedGoogle Scholar
• None. Classification of diabetic retinopathy from fluorescein angiograms. Ophthalmology. 1991;98(5):807–822.
   PubMedGoogle Scholar
• Association AD. Diabetic nephropathy. Diabetes Care. 2000; 23 Suppl 1: S69-72.
   Google Scholar
• Wang H, Le Zhang ZL, Wang X, et al. Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757.
   PubMed Web of Science ®Google Scholar
• Huang Y-Q, Liang C-H, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2015;2065:9128.
   Google Scholar
• Lätti S, Niinivehmas S, Pentikäinen OT. Rocker: open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization. J Cheminform. 2016;8(1):1–5. doi:10.1186/s13321-016-0158-y
   PubMedGoogle Scholar
• Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8(1):53. doi:10.1186/1472-6947-8-53
   PubMed Web of Science ®Google Scholar
• Lyu J, Li Z, Wei H, et al. A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China. Acta Diabetol. 2020;1–9.
   PubMedGoogle Scholar
• Li W, Xie B, Qiu S, et al. Non-lab and semi-lab algorithms for screening undiagnosed diabetes: a cross-sectional study. EBioMedicine. 2018;35:307–316. doi:10.1016/j.ebiom.2018.08.009
   PubMed Web of Science ®Google Scholar
• Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10):e017293.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532–2539.
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111
   PubMed Web of Science ®Google Scholar
• Lou J, Jing L, Yang H, et al. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: logistic regression and classification tree model analysis. Int J Health Plann Manage. 2019;34(3):1013–1024.
   PubMed Web of Science ®Google Scholar
• Sacks FM, Hermans MP, Fioretto P, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case–control study in 13 countries. Circulation. 2014;129(9):999–1008.
   PubMed Web of Science ®Google Scholar
• Tolonen N, Hietala K, Forsblom C, et al. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane study. J Intern Med. 2013;274(5):469–479. doi:10.1111/joim.12111
   PubMedGoogle Scholar
• Rooney D, Lye WK, Tan G, et al. Body mass index and retinopathy in Asian populations with diabetes mellitus. Acta Diabetol. 2015;52(1):73–80.
   PubMed Web of Science ®Google Scholar
• Sarrafan-Chaharsoughi Z, Manaviat MR, Namiranian N, et al. Is there a relationship between body mass index and diabetic retinopathy in type II diabetic patients? A cross sectional study. J Diabetes Nutr Metab Dis. 2018;17(1):63–69.
   PubMedGoogle Scholar
• Liu Z, Fu C, Wang W, et al. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes. 2010;8(1):62.
   PubMedGoogle Scholar
• Pedro R-A, Ramon S-A, Marc -B-B, et al. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17(4):251–265.
   PubMed Web of Science ®Google Scholar
• Fawwad A, Mustafa N, Zafar AB, et al. Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan. Pak J Med Sci. 2018;34(5):1058.
   PubMedGoogle Scholar
• Jiang S, Fang J, Yu T, et al. Novel Model predicts diabetic nephropathy in type 2 diabetes. Am J Nephrol. 2020;51(2):130–138.
   PubMed Web of Science ®Google Scholar
• Al-Rubeaan K, Youssef AM, Subhani SN, et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National diabetes registry-based study. PloS one. 2014;9(2).
   PubMedGoogle Scholar
• Inassi J, Vijayalakshmy R. Role of duration of diabetes in the development of nephropathy in type 2 diabetic patients. Nat J Med Res. 2013;3(1):5–8.
   Google Scholar
• Krairittichai U, Potisat S, Jongsareejit A, et al. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus. J Med Assoc Thai. 2011;94:S1–S5.
   PubMedGoogle Scholar
• Kwan JM, Hajjiri Z, Metwally A, et al. Effect of the obesity epidemic on kidney transplantation: obesity is independent of diabetes as a risk factor for adverse renal transplant outcomes. PloS one. 2016;11(11).
   Web of Science ®Google Scholar
• Cohen E, Fraser A, Goldberg E, et al. Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel. Nephrol Dial Transplant. 2013;28(suppl_4):iv130–iv135.
   PubMedGoogle Scholar
• Lu J, Hou X, Zhang L, et al. Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes. Acta Diabetol. 2015;52(4):701–708.
   PubMed Web of Science ®Google Scholar
• Larsen MB, Henriksen JE, Grauslund J, et al. Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark. Acta Ophthalmol (Copenh). 2017;95(8):778–786. doi:10.1111/aos.13449
   Google Scholar
• Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore malay eye study. Ophthalmology. 2008;115(11):1869–1875.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Yue S, Wu J, et al. Association of the serum total cholesterol to triglyceride ratio with diabetic retinopathy in chinese patients with type 2 diabetes: a community-based study. Diabetes Ther. 2019;10(2):597–604.
   PubMedGoogle Scholar
• Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc. 2009;49(5):S3–S9.
   Google Scholar
• United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6
   PubMedGoogle Scholar
• Foo V, Quah J, Cheung G, et al. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics: 亚洲 2 型糖尿病患者的 HbA1c 以及收缩压的变异性与糖尿病视网膜病变之间的关系. J Diabetes. 2017;9(2):200–207. doi:10.1111/1753-0407.12403
   PubMed Web of Science ®Google Scholar
• Pang C, Jia L, Jiang S, et al. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre‐diabetic subjects: shanghai diabetic complications study. Diabetes Metab Res Rev. 2012;28(3):276–283.
   PubMedGoogle Scholar
• Zhang G, Chen H, Chen W, et al. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–1595.
   PubMed Web of Science ®Google Scholar
• Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288–298. doi:10.1111/j.1463-1326.2009.01160.x
   PubMed Web of Science ®Google Scholar
• Chen W-Z, Hung -C-C, Wen Y-W, et al. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria. Ren Fail. 2014;36(2):171–175.
   PubMed Web of Science ®Google Scholar
• Yang Y-F, Li T-C, Li C-I, et al. Visit-to-visit glucose variability predicts the development of end-stage renal disease in type 2 diabetes: 10-year follow-up of Taiwan diabetes study. Medicine. 2015;94(44).
   Web of Science ®Google Scholar
• Skrha J, Soupal J, Skrha J Jr, et al. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17(1):103–110. doi:10.1007/s11154-016-9347-2
   PubMed Web of Science ®Google Scholar
• Cheng A; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Can J Diabetes. 2013;37:S1. doi:10.1016/j.jcjd.2013.01.009
   PubMedGoogle Scholar
• Li Q, Wang X, Ni Y, et al. Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women. Lipids Health Dis. 2019;18(1):155.
   PubMedGoogle Scholar